Idiotype-specific CD4+ T cells eradicate disseminated myeloma

Idiotypic DNA vaccination for the treatment of multiple myeloma: safety and immunogenicity in a phase I clinical study

(2015) Katy J. McCann et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

How Do CD4+ T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?

(2014) Ole Audun Werner Haabeth et al.   Frontiers in Immunology

Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity

(2012) S. Hong et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

A Novel Mouse Model for Multiple Myeloma (MOPC315.BM) That Allows Noninvasive Spatiotemporal Detection of Osteolytic Disease

(2012) Peter O. Hofgaard et al.   PLoS One

Secretion of Tumor-Specific Antigen by Myeloma Cells Is Required for Cancer Immunosurveillance by CD4+ T Cells

(2009) A. Corthay et al.   CANCER RESEARCH

Idiotype Vaccines for Human B-Cell Malignancies

(2009) S. Inoges et al.   CURRENT PHARMACEUTICAL DESIGN